Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07523880) titled 'Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD' on April 6.

Study Type: Observational

Primary Sponsor: Xueyan Zhao

Condition: Thrombosis Bleeding Coronary Artery Disease (CAD)

Recruitment Status: Recruiting

Date of First Enrollment: August 1, 2025

Target Sample Size: 12154

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07523880

Published by HT Digital Content Services with permission from Health Daily Digest....